<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03480607</url>
  </required_header>
  <id_info>
    <org_study_id>R/17.05.85</org_study_id>
    <nct_id>NCT03480607</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine as Adjuvant for Bupivacaine in Ultrasound Guided Infraorbital Nerve Block for Cleft Lip Repair</brief_title>
  <official_title>Comparative Evaluation of Dexamethasone and Dexmedetomidine as Adjuvants for Bupivacaine in Ultrasound Guided Infraorbital Nerve Block in Infants for Cleft Lip Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the efﬁcacy of dexamethasone versus dexmedetomidine as adjuncts to bupivacaine for&#xD;
      infra-orbital nerve block in infants undergoing cleft lip surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Regarding patient registry; A prior G power analysis was done. Using the results obtained&#xD;
      from previous studies and assuming an alpha error of 0.05 and beta error 0f 0.2 (power of the&#xD;
      study 80 %), a sample size of 20 patients per group was calculated. A drop out 10% of cases&#xD;
      is expected, so; 22 cases per group will be required.&#xD;
&#xD;
      Statistical analysis: Data will be analyzed through SPSS (Statistical Package for Social&#xD;
      Sciences). Program version 22. Distribution of data will be first tested by Shapiro test.&#xD;
      Data will be presented as mean and standard deviation (SD), median and range or numbers and&#xD;
      percentages. For normally distributed data, unpaired t test will be used to compare between&#xD;
      mean values of both groups. For pain and sedation scores, Mann Whitney U test will be used.&#xD;
      Fisher's exact test will be used for comparison of categorical data. The P value ≤ 0.05 will&#xD;
      be considered as the level of statistical significance.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2017</start_date>
  <completion_date type="Actual">May 10, 2018</completion_date>
  <primary_completion_date type="Actual">April 30, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative FLACC scale</measure>
    <time_frame>for 24 hours after surgery</time_frame>
    <description>FLACC scale: 0 : relaxed/ comfortable, 1-3 : mild discomfort, 4-6 : moderate discomfort, 7- 10: sever discomfort/ Pain / both,</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative sedation score</measure>
    <time_frame>for 4 hours after surgery</time_frame>
    <description>The degree of sedation will be assessed by using a three point sedation scale based on eye opening: - Alert with spontaneous eye opening 0, - Drowsy with eyes only opening in response to speech 1, - Sedated with eyes opening in response to physical stimulation 2,</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>For 4 hours after induction</time_frame>
    <description>(beat/min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic blood pressure</measure>
    <time_frame>For 4 hours after induction</time_frame>
    <description>(mmHg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea</measure>
    <time_frame>for 24 hours after surgery</time_frame>
    <description>As nausea can't be detected in this age group; so we will detect only if vomiting occur or not and number of attacks.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Haematoma formation after surgery</measure>
    <time_frame>for 24 hours after surgery</time_frame>
    <description>That will be scored as follows; Yes: there is hematoma formation or No: no hematoma formation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative vomiting</measure>
    <time_frame>for 24 hours after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Cleft Lip</condition>
  <arm_group>
    <arm_group_label>Dexmedetomidine group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dexmedetomidine in conjunction with bupivacaine for infra-orbital nerve block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexamethasone group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dexamethasone in conjunction with bupivacaine f</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine group</intervention_name>
    <description>0.75 ml of 0.5% Bupivacaine in conjunction with 0.5 mcg/kg dexmedetomidine</description>
    <arm_group_label>Dexmedetomidine group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone group</intervention_name>
    <description>0.75 ml of 0.5% Bupivacaine in conjunction with 0.1 mcg/kg dexamethasone</description>
    <arm_group_label>Dexamethasone group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  American society of anesthesiologist (ASA) physical status I or II&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  known allergy to any of drugs used&#xD;
&#xD;
          -  coagulopathy&#xD;
&#xD;
          -  any wound or infection related to puncture site&#xD;
&#xD;
          -  major illness&#xD;
&#xD;
          -  failure to gain consent of parents.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>1 Year</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Enas Abd el Motlb, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Mansoura University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mansoura University Childeren Hospital</name>
      <address>
        <city>Mansourah</city>
        <state>DK</state>
        <zip>050</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>March 7, 2018</study_first_submitted>
  <study_first_submitted_qc>March 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 29, 2018</study_first_posted>
  <last_update_submitted>September 3, 2020</last_update_submitted>
  <last_update_submitted_qc>September 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cleft Lip</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

